1st Edition

The Routledge International Handbook of Drug-Related Death Bereavement

460 Pages 8 B/W Illustrations
by Routledge

460 Pages 8 B/W Illustrations
by Routledge

This handbook provides a comprehensive overview of drug-related death bereavement to increase understanding and help direct scientific research, with contributions from across the globe.

It is the first comprehensive, cross-cultural, multidisciplinary review of research on drug-related death (DRD)bereavement. Chapters cover the impact of DRD at individual, family, cultural, and societal levels, and topics include working with, and social support for, families following drug-related loss, understanding grief processes of individuals, drug policy, and the importance of cultural contexts. The book also elaborates on methodological issues when researching DRD.

This handbook will increase understanding of DRD bereavement and contribute to support for DRD bereaved persons and those who care for them professionally and personally. It is essential reading for professionals and academics in the field as well as anyone affected by DRD.

 

PART I. SETTING THE STAGE 

1.     Introduction to the Handbook  

Margaret Stroebe, Kari Dyregrov and Kristine B. Titlestad 

2.     Researching drug-related death bereavement: Methodological suggestions for the study of key conceptual issues  

Eleftheria Tseliou and Georgios Abakoumkin 

3.     Drug-related death bereavement: Commentary by a bereaved parent on a research study 

Kelly Thomas, Kristine B. Titlestad, Margaret Stroebe, and Kari Dyregrov 

  

PART II. CONTEXT: THE SOCIETAL EMBEDDEDNESS OF BEREAVEMENT FOLLOWING A DRUG-RELATED DEATH  

4.     The importance of cultural context: A cross-cultural perspective on drug-death bereavement 

Paul C. Rosenblatt 

5.     Drug policy and welfare systems as context for drug-related death bereavement 

Svanaug Fjær and Kari Dyregrov 

6.     Disenfranchisement following a drug-related death 

Kenneth J. Doka and Kari Dyregrov   

7.     The impact of stigmatization before and after drug-related deaths 

Beatrice M. Wendeln, Madeline Oppenheim, Georg Schomerus, Patrick W. Corrigan 

 

PART III. CONSEQUENCES AND COPING (1): THE BEREAVEMENT EXPERIENCE FOLLOWING A DRUG-RELATED DEATH 

8.     Bereaved parents’ relationship following drug-related death loss: (What) can we learn from relationship research? 

Asuman Buyukcan-Tetik, Catrin Finkenauer, and Sara Albuquerque 

9.     Understanding parental grief on the death of a child who used narcotics 

William T. Feigelman and Kristine B. Titlestad 

10.  Risk factors for prolonged grief disorder in people bereaved by drug-related deaths 

Øyvind R. Kalsås and Maja O’Connor 

11.  Adjusting to loss after death from drug-related versus other traumatic deaths: Unique challenges? 

Jamison S. Bottomley, William T. Feigelman, and Alyssa A. Rheingold 

12.  Coping with bereavement due to drug-related death in the context of one’s own drug challenges 

Richard Velleman and Lillian Bruland Selseng 

13.  Patterns of coping following a drug-related death: An overview of the END project findings 

Kristine B. Titlestad, Lillian B. Selseng and Kari Dyregrov  

 

PART IV. CONSEQUENCES AND COPING (2): BEYOND THE WESTERN WORLD 

14.  Dealing with bereavement following a drug-related death in China 

Xinxian Liu and Suqin Tang 

15.  "Sℇ Asa”: Bereavement following bad deaths in Ghana    

Johnny Andoh-Arthur 

16.  Bereavement following a drug-related death in Mexico and India    

Richard Velleman, Marcela Tiburcio and Abhijit Nadkarni 

 

PART V. CARE (1): SUPPORTING BEREAVED PERSONS FOLLOWING A DRUG-RELATED DEATH 

17.  Guidance for supporting/counselling people bereaved through a drug-related death: Unique circumstances, special needs 

Peter Cartwright 

18.  Working with families following drug-death related loss  

Sari Lindeman and Lillian B. Selseng 

19.  On the provision of informal and formal support: From personal networks and colleagues, to schools, front line and health care providers 

Kari Dyregrov, Monika Reime and Sonja Mellingen 

20.  Stigma, kindness and professionalism: On fostering compassion and countering stigmatization 

Richard Velleman and Lorna Templeton 

21.  Belonging and empowerment: Experiences of community support following a drug-related death  

Joshua Stout and Benjamin Fleury-Steiner 

22.  Wall of Silence: Supporting providers after a drug-related death 

Adelya A. Urmanche and Kate Szymanski 

 

PART VI. CARE (2): TREATMENTS FOR DRUG-RELATED DEATH BEREAVED PERSONS IN NEED 

23.  Models of adaptation to bereavement: Application to grief therapy after a drug-related     death 

Jamison S. Bottomley and Robert A. Neimeyer 

24.  Prolonged Grief Disorder therapy for drug-related death bereaved, with insights from the Dual Process Model  

Henry Willis, Natalia Skritskaya, and M. Katherine Shear 

25.  Psychotherapeutic treatment for bereaved persons encountering grief difficulties following a drug-related death   

Jens C. Thimm and Pål Kristensen     

26.  Brief Eclectic Psychotherapy for prolonged and traumatic grief following drug-related death  

Geert Smid, Sophie M.C. Hengst, Joanna Wojtkowiak, Rebecca Gasser, and Paul A. Boelen    

27.  Structured support for adults bereaved by a drug-related death: The potential of the 5-Step Method 

Lorna Templeton 

28.  Rebuilding relationships: The benefits of increasing self-awareness through writing following a drug-related death 

Christina Thatcher 

 

PART VII. REFLECTIONS  

29.  Implications of the END project: Beyond the Norwegian context? 

Monika Reime, Lillian B. Selseng, Kristine B. Titlestad and Kari Dyregrov  

30.  The handbook under the magnifying glass: Lessons (still) to be learnt from the study of drug- 

related death bereavement 

Margaret Stroebe, Kari Dyregrov, and Kristine B. Titlestad 

Biography

Margaret Stroebe, PhD, is Professor Emerita and continuing visiting professor at the Department of Clinical Psychology, Utrecht University, and the Department of Clinical Psychology & Experimental Psychopathology, University of Groningen, Netherlands.

Kari Dyregrov, PhD, is Professor Emerita and continuing at the Faculty of Health and Social Sciences, Western Norway University of Applied Sciences, Bergen, Norway.

Kristine Berg Titlestad, PhD, is an associate professor at the Faculty of Health and Social Sciences, Western Norway University of Applied Sciences, Bergen, Norway.

''There is something so very reassuring to me, hearing that this Handbook is being compiled: how rare a thing it is, how needed it is, how wonderful that you and your colleagues are working on it. The silence around the topic is profound. The silence that people bereaved in this way experience is profound. The loss of friendships, networks, due to stigma, is profound. The change, on top of the loss ... it is all compounded. One adapts, and adapts. And adapts. And stays silent oneself.''

Anne Kellas, M.Ed, Australian poet whose talented, troubled son died from a drug-related death. Anne Kellas’s work has been published widely in Australia and overseas since the 1990s. 

''This book seeks to fill a large gap that has existed in thanatology since its inception: namely, the impact on the course of bereavement for individuals, families, and social networks when the mode of death is a drug-related overdose.  As such, I have no doubt that this comprehensive volume is destined to become the primary resource for this subject for many years to come. Drug overdose has been endemic for years in the developed world, but the mental health and social science professions have, for the most part, overlooked its impact. This excellent volume, edited by three well-established experts in the field, goes a long way towards closing that gap.'' 

John R. Jordan, Ph.D., clinician, grief counsellor and author of Grief After Suicide (2011) and Attachment Informed Grief Therapy (2016), both published by Routledge.

"This handbook is ambitious, impressive scholarship. The editors have achieved their aim: they have produced a book that offers an integrated synthesis of knowledge regarding drug-related death bereavement; going forward that synthesis will influence how drug-related death bereavement is understood. The scope of knowledge offered in this book and its clear integration will make the handbook an influential resource for clinical practitioners, researchers, faculty and students, and reference librarians."


David E. Balk (28 June 2024): Drug-related death bereavement across the globe, Death Studies, DOI: 10.1080/07481187.2024.2371148